
- Sermorelin ODT
- From $199/month
- Two-month package
- $349 ($175/month)
- FDA status
- Compounded, not FDA-approved
- Labs
- Billed separately
What your monthly price covers
The monthly price, from $199, includes a supply of compounded sermorelin as a dissolving tablet, prepared and dispensed by a licensed U.S. pharmacy, plus the clinical care around it. A licensed clinician reviews your history, symptoms and labs, decides whether sermorelin is a reasonable option, sets your plan and follows up to see how you're doing.
There is no membership fee. Shipping and any applicable taxes are shown before you pay, and you can stop after talking it through with your clinician.
Why sermorelin is only available compounded
Sermorelin was once sold as an FDA-approved injectable product under the brand name GEREF. The product was discontinued, and in 2013 the FDA published a determination that GEREF was not withdrawn from sale for reasons of safety or effectiveness. No FDA-approved sermorelin product is currently marketed, so the sermorelin available today is compounded.
Compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before they're sold. That's true of our sermorelin ODT as well. Most of the published human research on sermorelin used injections, and evidence for dissolving tablets is limited, which your clinician will discuss with you.
Budgeting for labs and monitoring
Sermorelin acts on the growth hormone axis, so clinicians usually check IGF-1, a blood marker that reflects growth hormone activity, before starting and again during treatment. A high baseline IGF-1, an active cancer or a suspected pituitary problem are reasons sermorelin may not be appropriate, and some of those situations need an in-person specialist evaluation.
Lab work is billed separately at our listed prices. A Comprehensive Lab Panel is $199 per draw; your clinician will tell you which tests you need and how often.
- Before starting: baseline labs, often including IGF-1
- During treatment: a follow-up check at the interval your clinician sets
- Ongoing: symptom review at each follow-up
What a trial period or a year might cost
At list price, three months of sermorelin ODT is $597 billed monthly, and twelve months is $2,388 billed monthly or $2,094 in 2-month packages, before labs. Because the evidence for sermorelin in healthy midlife adults is limited, it's reasonable to start with a defined trial, agree with your clinician on what you're hoping to see (such as better sleep quality or recovery), and review honestly before continuing.
Is sermorelin an alternative to testosterone or HRT?
No. Sermorelin works on growth hormone release, not on testosterone or estrogen. If your symptoms come from low testosterone or menopause, sermorelin won't treat the underlying cause. Testosterone Replacement Therapy is $249 for the first month then $149 per month, and Hormone Therapy for Women is $349 for the first month then $99 per month, if your clinician finds those more appropriate.
When sermorelin isn't the right spend
Sermorelin is not a good use of money if a different problem is driving your symptoms. Poor sleep, sleep apnea, low iron, thyroid disease, depression and overtraining can all look like "low growth hormone" and need their own care. Your clinician may recommend a lab panel or an in-person evaluation before prescribing anything.
It also isn't appropriate for everyone medically. Your clinician will usually avoid it if any of the following apply.
- Active cancer or a recent cancer history your oncologist hasn't cleared
- A suspected pituitary or hypothalamic disorder needing specialist workup
- A baseline IGF-1 that is already high
- Pregnancy or breastfeeding
How to compare sermorelin prices
Because there's no branded product, there's no manufacturer list price or retail generic to compare against. Prices vary by form (tablet or injection), whether labs and visits are bundled and how often you're reviewed. Compare the all-in monthly cost, including labs, and ask who monitors your IGF-1 and how often.
Be cautious about peptides sold online as "research chemicals" or "not for human use." They aren't prescribed for you, aren't prepared under pharmacy standards for patient use, and come without a clinician watching for problems.
Insurance, HSA and FSA
Insurance generally doesn't cover compounded sermorelin. For HSA and FSA funds, IRS rules count prescribed medicines as medical expenses but exclude expenses that are merely beneficial to general health. Your plan administrator decides whether sermorelin qualifies under your plan, and some may ask for a letter of medical necessity, so check before you pay and keep your receipts.
| Item | Price | Billing |
|---|---|---|
| Sermorelin ODT (compounded) | From $199/month | Monthly, or 2 months for $349 |
| Illustration: three-month trial | $597 | Three monthly payments, before labs |
| Comprehensive Lab Panel | $199 | One-time per panel |
| Testosterone Replacement Therapy (TRT), for comparison | $249 first month, then $149/month | Monthly |
Common questions
How much does sermorelin cost per month?
Sermorelin ODT starts at $199 per month at HealifyMD, or $349 for 2 months, including clinician oversight. Labs are billed separately.
Why isn't there an FDA-approved sermorelin?
The branded product, GEREF, was discontinued, and no approved version is marketed today. The FDA determined it wasn't withdrawn for safety or effectiveness reasons.
Do I need blood work?
Usually yes. Clinicians typically check IGF-1 before and during treatment to make sure levels stay in a safe range.
Is a tablet as effective as an injection?
That isn't well established. Most published human studies used injections, and data on dissolving tablets are limited.
Does insurance cover sermorelin?
Generally no, because it's compounded and not FDA-approved.
Can I use HSA or FSA money?
It depends on your plan. Ask your plan administrator before paying.
Can sermorelin replace testosterone therapy?
No. It acts on growth hormone, not testosterone, and doesn't treat diagnosed low testosterone.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- Determination That GEREF (Sermorelin Acetate) Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness (2013)Federal Register (U.S. Food and Drug Administration)
- Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration
- Publication 502: Medical and Dental ExpensesInternal Revenue Service